TOKYO —

New research from Columbia University Vagelos College of Physicians and Surgeons has unveiled a groundbreaking connection between the formation of new neurons in the adult brain and the protective mechanisms against depression. While the vast majority of the brain’s approximately 100 billion neurons are established before birth, a small but vital population of new neurons continues to emerge in a region known as the hippocampus. This ongoing neurogenesis, the process of generating new nerve cells, appears to be significantly diminished in individuals diagnosed with major depressive disorder, providing the first concrete evidence of its impairment in this condition. The findings, published in the prestigious journal Nature Medicine, not only illuminate a potential biological undergirding of depression but also point toward novel therapeutic avenues.

Historically, the understanding of depression has predominantly centered on imbalances in neurotransmitters, particularly serotonin. However, this new research challenges that simplified view, suggesting that depression is a far more complex disorder stemming from multifaceted issues that compromise the brain’s ability to adapt to stress and environmental changes. "Without the ability to create new neurons, people with depression may not have the resilience to effectively adapt to the environment," stated Maura Dupont, a professor of psychiatry and lead researcher on the study. This deficiency in neurogenesis could therefore hinder an individual’s capacity to navigate life’s challenges and maintain emotional equilibrium.

The Hippocampus: A Crucial Hub for Memory and Emotion

The focus of this extensive study was the hippocampus, a seahorse-shaped structure deep within the temporal lobe of the brain. This region is critically involved in the formation of episodic memories – autobiographical recollections of personal experiences – and in processing emotional responses to external stimuli. Crucially, the hippocampus is one of the few areas in the adult brain where neurogenesis persists throughout life. While depression is a complex condition affecting various brain regions, the hippocampus’s dual role in memory and emotion makes it a pivotal area for understanding the disorder’s impact. Researchers hypothesize that alterations within the hippocampus may contribute to the tendency among individuals with depression to interpret experiences through a consistently negative lens.

Professor Dupont elaborated on the hippocampus’s intricate function: "The hippocampus is important for our ability to distinguish between similar but different memories and separate the emotional connotation of past memories and current events." This sophisticated cognitive function is known as pattern separation. When pattern separation is compromised, the distinctiveness between individual memories and their associated emotional valence can blur. This blending can lead to a distorted perception of reality, where current events become conflated with past negative experiences.

"You may be out with a friend for lunch, but she’s tired and doesn’t talk much. With intact pattern separation, you remember this as a unique event. With impaired pattern separation, it becomes mixed with previous memories of feeling rejected, leading you to think, ‘They’re upset with me’," explained Dupont. "And I see this a lot in my patients, where they can only retrieve negative information from their memories." This phenomenon underscores how impaired neurogenesis in the hippocampus could perpetuate negative thought cycles, a hallmark of depression.

Evidence from animal studies has previously established a link between adult neurogenesis and pattern separation. Furthermore, a recent study involving human patients with brain tumors, where hippocampal radiation therapy led to the elimination of neurogenesis, has provided suggestive evidence of a similar relationship in humans. The implication is that these newly formed neurons are particularly sensitive to novel experiences and can be readily integrated into new memory circuits. This process allows for the distinct storage of new memories, preventing them from being overshadowed by older, potentially negative ones. "Turning neurogenesis back on may be a way to treat depression in some people by rewiring their hippocampus circuit," Dupont suggested, highlighting the potential therapeutic implications.

Beyond Neurogenesis: A Wider Network of Disruption

The Columbia University study’s implications extend far beyond the mere absence of new neuron growth. The researchers discovered that the molecular disruptions associated with depression permeated a larger hippocampal circuit responsible for storing episodic memories and their emotional significance. This comprehensive analysis revealed alterations in genes crucial for several fundamental cellular processes within this circuit, including:

  • Synaptic Plasticity: Genes involved in building new connections between neurons, the very foundation of learning and memory.
  • Neuronal Communication: Genes supporting the efficient transmission of signals among brain cells, essential for coordinated brain function.
  • Cellular Energy Metabolism: Genes responsible for supplying the energy required for neuronal activity and survival.
  • Intracellular Transport: Genes that regulate the movement of materials within cells, ensuring proper functioning of cellular components.

The trisynaptic circuit, a primary pathway within the hippocampus for the establishment of new emotional memories, also exhibited signs of inflammation and cellular stress in individuals with depression. This finding suggests a broader pathological process affecting neuronal health and function within this critical memory-encoding system.

A Deep Dive into Cellular and Molecular Mechanisms

To achieve these comprehensive insights, the research team meticulously analyzed nearly half a million individual brain cells obtained from individuals diagnosed with depression and from control subjects. These samples were collected shortly after the donors’ deaths, allowing for a detailed examination of cellular states and gene expression. Employing a suite of advanced single-cell genomics techniques, the scientists were able to measure the activity of every gene within each individual cell. They also examined alterations in cellular proteins, providing a granular understanding of cellular function. This massive dataset enabled the researchers to pinpoint the specific activities of individual cells and precisely locate the affected cells within the complex hippocampal circuit.

The Interplay of Genes, Environment, and Depression

The detailed molecular profiling revealed altered activity in several genes whose known genetic variants have been previously implicated in major depressive disorder. This finding strengthens the genetic underpinnings of the observed cellular dysregulation.

Furthermore, the study identified epigenetic changes in other disrupted genes. Epigenetic mechanisms, often described as "dimmer switches" for gene activity, can modify how strongly genes are expressed without altering the underlying DNA sequence. These changes are known to be influenced by a multitude of environmental factors, including stress, learning experiences, aging, and exposure to various chemicals. "These are like dimmer switches that control how active genes are, and they are affected by life experiences such as stress, learning, aging, chemicals, etc.," explained Dupont. The presence of these epigenetic modifications suggests that environmental factors likely play a significant role in triggering or exacerbating the biological changes associated with depression.

The sheer diversity of these molecular alterations offers a compelling explanation for the heterogeneous presentation of depression across individuals. "The wide range of effects we found could reflect different pathogenetic mechanisms, perhaps indicating that depression is not just one disease," Dupont commented. This suggests that depression may not be a monolithic disorder but rather a spectrum of conditions with distinct underlying biological profiles.

While the underlying biology of depression remains a complex and evolving area of study, research efforts like this one are crucial for precisely defining the disorder at the cellular and molecular levels. Such detailed characterization is essential for identifying novel therapeutic targets and developing more effective treatments.

Towards Molecular Subtypes: A New Paradigm for Depression Treatment

Looking forward, Professor Dupont and her colleagues aspire to reclassify depression based on its distinct molecular characteristics, drawing a parallel to the advancements made in cancer research. In oncology, the classification of cancers based on their cellular and molecular profiles, rather than their anatomical location, has revolutionized treatment strategies, leading to more targeted and effective therapies.

"We want to reclassify depression based on its molecular features, similar to what has been done in cancer," Dupont articulated. "Classifying cancers based on their cellular characteristics, not their locations, has led to new and improved treatments. We hope the same will be true for depression and other psychiatric or brain diseases." This ambitious goal aims to move beyond a generalized diagnosis of depression towards a more personalized approach, where treatments are tailored to the specific biological mechanisms at play in an individual patient.

The groundbreaking study, titled "Dysregulated adult hippocampal neurogenesis in major depressive disorders," was published on August 21, 2026, in the esteemed journal Nature Medicine. The collaborative effort involved a multidisciplinary team from Columbia University and the New York State Psychiatric Institute, with contributions from researchers at Ss. Cyril and Methodius University in Macedonia.

The research was conducted within the Maura Dupont lab at Columbia University Irving Medical Center and the New York State Psychiatric Institute. Advanced sequencing was performed at the JP Sulzberger Columbia Genome Center, data clustering was facilitated by Columbia’s Center for Computational Biology and Bioinformatics, and proteomics analyses were carried out at Columbia University’s Department of Biology’s Quantitative Proteomics and Metabolomics Center, underscoring the sophisticated technological infrastructure that supported this pivotal investigation.